| Product NDC: | 0245-0536 |
| Proprietary Name: | Cholestyramine |
| Non Proprietary Name: | Cholestyramine |
| Active Ingredient(s): | 4 g/9g & nbsp; Cholestyramine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0245-0536 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074557 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120105 |
| Package NDC: | 0245-0536-37 |
| Package Description: | 378 g in 1 CAN (0245-0536-37) |
| NDC Code | 0245-0536-37 |
| Proprietary Name | Cholestyramine |
| Package Description | 378 g in 1 CAN (0245-0536-37) |
| Product NDC | 0245-0536 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cholestyramine |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20120105 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | CHOLESTYRAMINE |
| Strength Number | 4 |
| Strength Unit | g/9g |
| Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |